Recent progress in elucidating the relationship between senescence and disease progression is summarized and representative delivery strategies that demonstrate superior therapeutic potential are shown.
Abstract
Senescence has emerged as a promising therapeutic target in diverse age-related diseases and cancer, owing to its critical roles in tissue homeostasis, chronic inflammation, and tumor progression. Accumulating evidence indicates that senescent cells contribute to disease pathology through various pathophysiological mechanisms. Despite growing interest in exploiting senescence for therapeutic benefit, achieving precise and controllable senescence modulation remains challenging. Current strategies, including senolytics that selectively eliminate senescent cells and senomorphics that suppress senescence-associated secretory phenotype factors, often suffer from limited specificity, off-target toxicity, and inadequate control over treatment timing and dosage. To overcome these limitations, recent research has increasingly focused on interdisciplinary approaches that integrate advances in materials science, nanotechnology, and molecular biology, particularly through the development of advanced delivery systems designed to improve targeting efficiency and therapeutic outcomes. In this review, we summarize recent progress in elucidating the relationship between senescence and disease progression and show representative delivery strategies that demonstrate superior therapeutic potential. Senescence appears to be an encouraging therapeutic target in various diseases. The clinical translation of conventional senotherapeutics remains a major challenge. Advanced drug delivery systems for the targeted modulation of senescent cells exhibit significant promise. Senescence appears to be an encouraging therapeutic target in various diseases. The clinical translation of conventional senotherapeutics remains a major challenge. Advanced drug delivery systems for the targeted modulation of senescent cells exhibit significant promise.
The biological mechanisms regulating cellular senescence are summarized, its contrasting roles in cancer development are highlighted, emerging therapeutic approaches are discussed, and current challenges and future directions for translating senescence-based therapies into clinical oncology are outlined.
Awateef Fatima, Saba Yousuf· International Journal of Inn...· 0 citations
A comprehensive review aims to consolidate the current understanding of cellular senescence and its pathological consequences, and presents an in-depth analysis of studies employing nano-drug delivery systems in cellular senescence research, emphasizing their potential role and prospects.
It is shown that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors, which establishes SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.
Clemens Hinterleitner, Valentin J. A. Barthet, Hailey V. Goldberg et al.· Science· 1 citation
This review focuses on the molecular and cellular mechanisms through which SnCs modulate immune composition and function, emphasizing immune checkpoint ligands, stress-associated surface molecules, and senescence-associated transcriptional programs governing senescence-associated secretory phenotype (SASP) expression.
Fernanda Saez-Calazans, L. Grun, Lucas Emanuel Stein et al.· Ageing Research Reviews· 0 citations
Overall, current data support a context-dependent role for persistent senescence in treatment resistance, but do not establish TIS as a universal or independent cause of therapeutic failure.
Cellular senescence is one of the major risk factors for the onset and progression of chronic pulmonary diseases. Cellular senescence can be induced by diverse stressors, including genotoxic damage, oncogenic signaling, and therapeutic interventions. These senescent cells communicate via the release of multiple inflamm...
Shravani Etrouth, Yin Zhu, Duo Zhang· Journal of Respiration· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.